Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis greenmarketreport Views: 361

-

The country’s leading e-commerce company Amazon (NASDAQ: AMZN) posted a notice to its U.S. Operations employees from Dave Clark, CEO, Worldwide Consumer regarding the testing for marijuana use with its employees. 

The blog post read, “We’re adjusting our drug testing policy. In the past, like many employers, we’ve disqualified people from working at Amazon if they tested positive for marijuana use. However, given where state laws are moving across the U.S., we’ve changed course. We will no longer include marijuana in our comprehensive drug screening program for any positions not regulated by the Department of Transportation, and will instead treat it the same as alcohol use. We will continue to do impairment checks on the job and will test for all drugs and alcohol after any incident.”

went on to say, “And because we know that this issue is bigger than Amazon, our public policy team will be actively supporting The Marijuana Opportunity Reinvestment and Expungement Act of 2021 (MORE Act)—federal legislation that would legalize marijuana at the federal level, expunge criminal records, and invest in impacted communities. We hope that other employers will join us and that policymakers will act swiftly to pass this law.”

The move could set a precedent for other larger employers across the board as Amazon has now laid down the challenge.

Steve Allan, CEO of The Parent Company said, “Amazon’s recent announcement that it has evolved its position on cannabis both as an employer and through its public advocacy efforts represents a watershed moment in the long-standing effort to federally legalize cannabis, reform our criminal justice system, and create a more socially equitable society. As one of the largest employers in the country, Amazon’s announcement that it will no longer screen job applicants and employees for cannabis use, unless required to do so by the Department of Transportation, sets a robust precedent that has the potential to reshape hiring practices across the country.

Employment drug tests were adopted at the height of the War on Drugs in the late 1980’s, and in the ensuing decades these unnecessary tests disproportionately impacted low-income Americans and communities of color, limiting their access to economic opportunity. By helping establish a norm against such discriminatory hiring practices, Amazon can help undo one of the most damaging legacies of cannabis criminalization in this country.

Amazon’s complementary announcement that it will be publicly advocating for the passage of The MORE Act is also highly significant and unprecedented for a company of its size. The MORE Act would decriminalize cannabis at the federal level, expunge the criminal records of non-violent cannabis offenders, and allocate tax revenue generated by the legal cannabis industry to communities disproportionately impacted by the War on Drugs. We at The Parent Company have always felt that the private sector plays such a critical role in pushing for equitable, progressive cannabis legislation. Due to the public clout of companies like Amazon, their support for progressive cannabis reforms will prove instrumental as we approach the final stages of federal legalization. “

Amazon Says It Will No Longer Test For Cannabis Use on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.